
Company valuation, historical trends, and peer comparisons.
According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 82.37M. This represents a change of -5.06% compared to the average of 86.76M of the last 4 quarters.
The mean historical Enterprise Value of NRx Pharmaceuticals, Inc. over the last ten years is 380.17M. The current 82.37M Enterprise Value has changed -78.33% with respect to the historical average. Over the past ten years (40 quarters), NRXP's Enterprise Value was at its highest in in the September 2021 quarter at 5.04B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.
Average
380.17M
Median
87.01M
Minimum
28.27M
Maximum
2.22B
Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.57%
Maximum Annual Enterprise Value = 2.22B
Minimum Annual Increase = -94.53%
Minimum Annual Enterprise Value = 28.27M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 50.83M | 79.80% |
| 2024 | 28.27M | -28.27% |
| 2023 | 39.42M | -94.53% |
| 2022 | 720.48M | -67.48% |
| 2021 | 2.22B | 1.57% |
| 2020 | 132.30M | 136.73% |
| 2019 | 55.89M | -39.06% |
| 2018 | 91.71M | 5.40% |
The current Enterprise Value of NRx Pharmaceuticals, Inc. (NRXP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
39.51M
5-year avg
610.92M
10-year avg
380.17M
NRx Pharmaceuticals, Inc.’s Enterprise Value is less than Cue Biopharma, Inc. (135.54M), less than Outlook Therapeutics, Inc. (119.69M), greater than Spruce Biosciences, Inc. (45.33M), less than Coeptis Therapeutics Holdings, Inc. (175.84M), greater than Werewolf Therapeutics, Inc. (30.99M), greater than Equillium, Inc. (32.19M), less than Karyopharm Therapeutics Inc. (162.56M), greater than IO Biotech, Inc. (-28323310.00), less than Century Therapeutics, Inc. (287.38M), greater than Senti Biosciences, Inc. (19.26M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 135.54M | $144.13M | |
| 119.69M | $112.50M | |
| 45.33M | $133.96M | |
| 175.84M | $38.62M | |
| 30.99M | $52.97M | |
| 32.19M | $88.77M | |
| 162.56M | $1.65M | |
| -28323310.00 | $885.69K | |
| 287.38M | $302.40M | |
| 19.26M | $5.50M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NRx Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP)?
What is the 3-year average Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP)?
What is the 5-year average Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP)?
How does the current Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP) compare to its historical average?